Jianguo Zhou

Department of Radiation Oncology

Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma – knowledge obtained from the CheckRad-CD8 trial (2024) Hecht M, Frey B, Gaipl U, Tianyu X, Eckstein M, Donaubauer AJ, Klautke G, et al. Journal article TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy (2024) Wang S, Xiong Y, Zhang Y, Wang H, Chen M, Li J, Luo P, et al. Journal article Effects of serial radon spa therapy on pain and peripheral immune status in patients suffering from musculoskeletal disorders– results from a prospective, randomized, placebo-controlled trial (2024) Donaubauer AJ, Becker I, Klein G, Voll RE, Weikl L, Klieser M, Barzangi S, et al. Journal article Editorial: Recent advances in genetic and proteomic biomarkers involved in the early detection of solid tumors (2023) Li J, Chen A, Zhang R, Li C, Zhou J, Fang B, Jiang Y Journal article Updated analysis of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma with induction chemoimmunotherapy followed by radioimmunotherapy (2022) Hecht M, Eckstein M, Kallies A, von der Grün J, Illmer T, Klautke G, Laban S, et al. Conference contribution, Abstract of a poster Identification of an endogenous retroviral signature to predict anti-PD1 response in advanced clear cell renal cell carcinoma: an integrated analysis of three clinical trials (2022) Zhou J, Zeng Y, Wang H, Jin SH, Wang YJ, He S, Frey B, et al. Journal article Editorial: Uncovering Drug Resistance During Cancer Therapy (2022) Wang H, Wang RH, Zhou J, Hou W, Wong AHH Journal article Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer (2022) Hecht M, Eckstein M, Rutzner S, von der Grün J, Illmer T, Klautke G, Laban S, et al. Journal article Low-Dose Radiotherapy Leads to a Systemic Anti-Inflammatory Shift in the Pre-Clinical K/BxN Serum Transfer Model and Reduces Osteoarthritic Pain in Patients (2022) Weissmann T, Rückert M, Zhou J, Seeling M, Lettmaier S, Donaubauer AJ, Nimmerjahn F, et al. Journal article Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors (2021) Griewing LM, Schweizer C, Schubert P, Rutzner S, Eckstein M, Frey B, Haderlein M, et al. Journal article